pmc logo imageJournal ListSearchpmc logo image
Logo of brjclinpharmJournal URL: redirect3.cgi?&&auth=0xyrE0viJmiwbGJymK3CdcKvAFMXggnOLjf99pkzh&reftype=publisher&artid=1429012&article-id=1429012&iid=130041&issue-id=130041&jid=279&journal-id=279&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://www.blackwellpublishing.com/journal.asp?ref=0306-5251
Br J Clin Pharmacol. 1977 April; 4(2): 97–100.
PMCID: PMC1429012
Oral absorption and secretion of drugs.
C F Speirs
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (556K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Beckett AH BOYES, RN; Triggs, EJ. Kinetics of buccal absorption of amphetamines. J Pharm Pharmacol. 1968 Feb;20(2):92–97. [PubMed]
  • Beckett, AH; Moffat, AC. Kinetics of buccal absorption of some carboxylic acids and the correlation of the rate constants and n-heptane: aqueous phase partition coefficients. J Pharm Pharmacol. 1970 Jan;22(1):15–19. [PubMed]
  • Beckett, AH; Moffat, AC. The buccal absorption of some barbiturates. J Pharm Pharmacol. 1971 Jan;23(1):15–18. [PubMed]
  • BENDER, IB; PRESSMAN, RS; TASHMAN, SG. Studies on excretion of antibiotics in human saliva. I. Penicillin and streptomycin. J Am Dent Assoc. 1953 Feb;46(2):164–170. [PubMed]
  • Brooks, PM; Bell, MA; Burns, H. Salivary antipyrine half-life: a useful measure of hepatic drug metabolism. Br J Clin Pharmacol. 1976 Oct;3(5):945–946. [PubMed]
  • Chang, RL; Wood, AW; Dixon, WR; Conney, AH; Anderson, KE; Eiseman, J; Alvares, AP. Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose. Clin Pharmacol Ther. 1976 Aug;20(2):219–226. [PubMed]
  • Fraser, HS; Bulpitt, CJ; Kahn, C; Mould, G; Mucklow, JC; Dollery, CT. Factors affecting antipyrine metabolism in West African villagers. Clin Pharmacol Ther. 1976 Sep;20(3):369–376. [PubMed]
  • Galeazzi, RL; Benet, LZ; Sheiner, LB. Relationship between the pharmacokinetics and pharmacodynamics of procainamide. Clin Pharmacol Ther. 1976 Sep;20(3):278–289. [PubMed]
  • George, CF. Diseases of the alimentary system. Absorption, distribution, and metabolism of drugs; effects of disease of the gut. Br Med J. 1976 Sep 25;2(6038):742–744. [PubMed]
  • GIBALDI, M; KANIG, JL. ABSORPTION OF DRUGS THROUGH THE ORAL MUCOSA. J Oral Ther Pharmacol. 1965 Jan;31:440–450. [PubMed]
  • Glynn, JP; Bastain, W. Salivary excretion of paracetamol in man. J Pharm Pharmacol. 1973 May;25(5):420–421. [PubMed]
  • Graham, G; Rowland, M. Application of salivary salicylate data to biopharmaceutical studies of salicylates. J Pharm Sci. 1972 Aug;61(8):1219–1222. [PubMed]
  • Hoeprich, PD. Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis. 1971 Feb;123(2):125–133. [PubMed]
  • Huffman, DH. Relationship between digoxin concentrations in serum and saliva. Clin Pharmacol Ther. 1975 Mar;17(3):310–312. [PubMed]
  • Inaba, T; Kalow, W. Salivary excretion of amobarbital in man. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):558–562. [PubMed]
  • Joselow, MM; Ruiz, R; Goldwater, LJ. The use of salivary (parotid) fluid in biochemical monitoring. Am Ind Hyg Assoc J. 1969 30(1):77–82.Jan–Feb; [PubMed]
  • Koysooko, R; Ellis, EF; Levy, G. Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther. 1974 May;15(5):454–460. [PubMed]
  • Matin, SB; Wan, SH; Karam, JH. Pharmacokinetics of tolbutamide: prediction by concentration in saliva. Clin Pharmacol Ther. 1974 Dec;16(6):1052–1058. [PubMed]
  • Salivary concentrations of antiepileptic drugs. Lancet. 1976 Sep 18;2(7986):639–640. [PubMed]
  • Paxton, JW; Whiting, B; Stephen, KW. Phenytoin concentrations in mixed, parotid and submandibular saliva and serum measured by radioimmunoassay. Br J Clin Pharmacol. 1977 Apr;4(2):185–191. [PubMed]
  • Reynolds, F; Ziroyanis, PN; Jones, NF; Smith, SE. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet. 1976 Aug 21;2(7982):384–386. [PubMed]
  • Letter: Exercise and the heart. Lancet. 1976 Mar 20;1(7960):639–640. [PubMed]
  • Schmidt, D; Kupferberg, J. Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia. 1975 Dec;16(5):735–741. [PubMed]
  • Speirs, CF; Stenhouse, D; Stephen, KW; Wallace, ET. Comparison of human serum, parotid and mixed saliva levels of phenoxymethylpenicillin, ampicillin, cloxacillin and cephalexin. Br J Pharmacol. 1971 Sep;43(1):242–247. [PubMed]
  • Stephen, KW; Speirs, CF. Methods for collecting individual components of mixed saliva: the relevance to clinical pharmacology. Br J Clin Pharmacol. 1976 Apr;3(2):315–319. [PubMed]